发明名称 |
Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
摘要 |
By suitable retardation oral pharmaceutical compositions containing propiverine or one or several pharmaceutically acceptable salts thereof in an amount of 4 mg to 60 mg propiverine and having a prolonged release of the active agent are produced. Preferably a blend of active agent and optionally one or more acidic substances having a pKa value of less than 6.65 are provided with a retarding coating or are embedded in a matrix which is then optionally coated with further retarding layers.
|
申请公布号 |
US2004258749(A1) |
申请公布日期 |
2004.12.23 |
申请号 |
US20040492270 |
申请日期 |
2004.04.08 |
申请人 |
GULDNER PETER;HESCHEL MICHAEL;PAMPERIN DIRK;PLOEN JAN;SCHEITHAUSER STEFFEN;WEHNER WOLFGANG;GRAMATTE THOMAS |
发明人 |
GULDNER PETER;HESCHEL MICHAEL;PAMPERIN DIRK;PLOEN JAN;SCHEITHAUSER STEFFEN;WEHNER WOLFGANG;GRAMATTE THOMAS |
分类号 |
A61K9/10;A61K9/14;A61K9/20;A61K9/22;A61K9/28;A61K9/32;A61K9/48;A61K9/50;A61K9/52;A61K31/445;A61K47/12;A61K47/22;A61K47/26;A61K47/32;A61K47/36;A61K47/38;A61K47/42;A61K47/44;A61K47/46;(IPC1-7):A61K31/445 |
主分类号 |
A61K9/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|